Skip to main content
Top
Published in: Forensic Science, Medicine and Pathology 3/2016

01-09-2016 | Review

Caffeine toxicity in forensic practice: possible effects and under-appreciated sources

Authors: Ian F. Musgrave, Rachael L. Farrington, Claire Hoban, Roger W. Byard

Published in: Forensic Science, Medicine and Pathology | Issue 3/2016

Login to get access

Abstract

Caffeine is considered a very safe stimulant and is widely consumed in a variety of forms, from pure caffeine to beverages and foods. Typically, death is only seen when gram quantities of caffeine are consumed, usually in suicide attempts. Even in this scenario, death is rare. However, there are special populations that need to be considered in forensic presentations, who may be at greater risk. These include poor metabolizers, people with liver disease, and people with cardiac conditions, who can die as a result of caffeine intake at levels well below what is ordinarily considered toxic. Also, caffeine intake may be hidden. For example, herbal medicines with substantial caffeine content may not disclose these concentrations on their product label. The role of caffeine in medicolegal deaths is yet to be defined, however, herbal medicines and herbal weight loss supplements may represent an underappreciated source of caffeine in this context.
Literature
1.
go back to reference Panel EN. Scientific opinion on the safety of caffeine. EFSA J. 2015;13:120. Panel EN. Scientific opinion on the safety of caffeine. EFSA J. 2015;13:120.
2.
go back to reference Dalvi RR. Acute and chronic toxicity of caffeine: a review. Vet Hum Toxicol. 1986;28:144–50.PubMed Dalvi RR. Acute and chronic toxicity of caffeine: a review. Vet Hum Toxicol. 1986;28:144–50.PubMed
3.
go back to reference Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol. 2014;180:763–75.CrossRefPubMed Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol. 2014;180:763–75.CrossRefPubMed
4.
go back to reference Loftfield E, Freedman ND, Graubard BI, Guertin KA, Black A, Huang WY, et al. Association of Coffee consumption with overall and cause-specific mortality in a large US prospective cohort study. Am J Epidemiol. 2015;182:1010–22.PubMed Loftfield E, Freedman ND, Graubard BI, Guertin KA, Black A, Huang WY, et al. Association of Coffee consumption with overall and cause-specific mortality in a large US prospective cohort study. Am J Epidemiol. 2015;182:1010–22.PubMed
5.
6.
go back to reference Schimpl FC, da Silva JF, Goncalves JF, Mazzafera P. Guarana: revisiting a highly caffeinated plant from the Amazon. J Ethnopharmacol. 2013;150:14–31.CrossRefPubMed Schimpl FC, da Silva JF, Goncalves JF, Mazzafera P. Guarana: revisiting a highly caffeinated plant from the Amazon. J Ethnopharmacol. 2013;150:14–31.CrossRefPubMed
7.
go back to reference Tunnicliffe JM, Erdman KA, Reimer RA, Lun V, Shearer J. Consumption of dietary caffeine and coffee in physically active populations: physiological interactions. Appl Physiol Nutr Metab. 2008;33:1301–10.CrossRefPubMed Tunnicliffe JM, Erdman KA, Reimer RA, Lun V, Shearer J. Consumption of dietary caffeine and coffee in physically active populations: physiological interactions. Appl Physiol Nutr Metab. 2008;33:1301–10.CrossRefPubMed
9.
go back to reference Pendleton M, Brown S, Thomas CM, Odle B. Potential toxicity of caffeine when used as a dietary supplement for weight loss. J Diet Suppl. 2013;10:1–5.CrossRefPubMed Pendleton M, Brown S, Thomas CM, Odle B. Potential toxicity of caffeine when used as a dietary supplement for weight loss. J Diet Suppl. 2013;10:1–5.CrossRefPubMed
10.
go back to reference Cannon ME, Cooke CT, McCarthy JS. Caffeine-induced cardiac arrhythmia: an unrecognised danger of healthfood products. Med J Aust. 2001;174:520–1.PubMed Cannon ME, Cooke CT, McCarthy JS. Caffeine-induced cardiac arrhythmia: an unrecognised danger of healthfood products. Med J Aust. 2001;174:520–1.PubMed
11.
go back to reference Banerjee P, Ali Z, Levine B, Fowler DR. Fatal caffeine intoxication: a series of eight cases from 1999 to 2009. J Forensic Sci. 2014;59:865–8.CrossRefPubMed Banerjee P, Ali Z, Levine B, Fowler DR. Fatal caffeine intoxication: a series of eight cases from 1999 to 2009. J Forensic Sci. 2014;59:865–8.CrossRefPubMed
12.
go back to reference Bonsignore A, Sblano S, Pozzi F, Ventura F, Dell’Erba A, Palmiere C. A case of suicide by ingestion of caffeine. Forensic Sci Med Pathol. 2014;10:448–51.CrossRefPubMed Bonsignore A, Sblano S, Pozzi F, Ventura F, Dell’Erba A, Palmiere C. A case of suicide by ingestion of caffeine. Forensic Sci Med Pathol. 2014;10:448–51.CrossRefPubMed
13.
go back to reference Jabbar SB, Hanly MG. Fatal caffeine overdose: a case report and review of literature. Am J Forensic Med Pathol. 2013;34:321–4.CrossRefPubMed Jabbar SB, Hanly MG. Fatal caffeine overdose: a case report and review of literature. Am J Forensic Med Pathol. 2013;34:321–4.CrossRefPubMed
14.
go back to reference Silva AC, de Oliveira Ribeiro NP, de Mello Schier AR, Pereira VM, Vilarim MM, Pessoa TM, et al. Caffeine and suicide: a systematic review. CNS Neurol Disord: Drug Targets. 2014;13:937–44.CrossRef Silva AC, de Oliveira Ribeiro NP, de Mello Schier AR, Pereira VM, Vilarim MM, Pessoa TM, et al. Caffeine and suicide: a systematic review. CNS Neurol Disord: Drug Targets. 2014;13:937–44.CrossRef
15.
go back to reference Yamamoto T, Yoshizawa K, Kubo S, Emoto Y, Hara K, Waters B, et al. Autopsy report for a caffeine intoxication case and review of the current literature. J Toxicol Pathol. 2015;28:33–6.CrossRefPubMed Yamamoto T, Yoshizawa K, Kubo S, Emoto Y, Hara K, Waters B, et al. Autopsy report for a caffeine intoxication case and review of the current literature. J Toxicol Pathol. 2015;28:33–6.CrossRefPubMed
16.
go back to reference Dorne JL, Walton K, Renwick AG. Uncertainty factors for chemical risk assessment: human variability in the pharmacokinetics of CYP1A2 probe substrates. Food Chem Toxicol. 2001;39:681–96.CrossRefPubMed Dorne JL, Walton K, Renwick AG. Uncertainty factors for chemical risk assessment: human variability in the pharmacokinetics of CYP1A2 probe substrates. Food Chem Toxicol. 2001;39:681–96.CrossRefPubMed
17.
go back to reference Kashuba AD, Bertino JS Jr, Kearns GL, Leeder JS, James AW, Gotschall R, et al. Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping. Clin Pharmacol Ther. 1998;63:540–51.CrossRefPubMed Kashuba AD, Bertino JS Jr, Kearns GL, Leeder JS, James AW, Gotschall R, et al. Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping. Clin Pharmacol Ther. 1998;63:540–51.CrossRefPubMed
18.
go back to reference Wang L, Hu Z, Deng X, Wang Y, Zhang Z, Cheng ZN. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers. Basic Clin Pharmacol Toxicol. 2013;112:257–63.CrossRefPubMed Wang L, Hu Z, Deng X, Wang Y, Zhang Z, Cheng ZN. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers. Basic Clin Pharmacol Toxicol. 2013;112:257–63.CrossRefPubMed
19.
go back to reference Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006;295:1135–41.CrossRefPubMed Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006;295:1135–41.CrossRefPubMed
21.
go back to reference Busuttil M, Willoughby S. A survey of energy drink consumption among young patients presenting to the emergency department with the symptom of palpitations. Int J Cardiol. 2016;204:55–6.CrossRefPubMed Busuttil M, Willoughby S. A survey of energy drink consumption among young patients presenting to the emergency department with the symptom of palpitations. Int J Cardiol. 2016;204:55–6.CrossRefPubMed
22.
go back to reference Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008;64:1147–61.CrossRefPubMed Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008;64:1147–61.CrossRefPubMed
23.
go back to reference Cheston P, Smith L. Man died after overdosing on caffeine mints. Independent. 2013. Cheston P, Smith L. Man died after overdosing on caffeine mints. Independent. 2013.
24.
go back to reference Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet. 2000;39:127–53.CrossRefPubMed Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet. 2000;39:127–53.CrossRefPubMed
25.
go back to reference George J, Murphy T, Roberts R, Cooksley WG, Halliday JW, Powell LW. Influence of alcohol and caffeine consumption on caffeine elimination. Clin Exp Pharmacol Physiol. 1986;13:731–6.CrossRefPubMed George J, Murphy T, Roberts R, Cooksley WG, Halliday JW, Powell LW. Influence of alcohol and caffeine consumption on caffeine elimination. Clin Exp Pharmacol Physiol. 1986;13:731–6.CrossRefPubMed
26.
go back to reference Ciszowski K, Biedron W, Gomolka E. Acute caffeine poisoning resulting in atrial fibrillation after guarana extract overdose. Przegl Lek. 2014;71:495–8.PubMed Ciszowski K, Biedron W, Gomolka E. Acute caffeine poisoning resulting in atrial fibrillation after guarana extract overdose. Przegl Lek. 2014;71:495–8.PubMed
27.
go back to reference Bryczkowski C, Geib AJ. Combined butalbital/acetaminophen/caffeine overdose: case files of the Robert Wood Johnson Medical School Toxicology Service. J Med Toxicol. 2012;8:424–31.CrossRefPubMedPubMedCentral Bryczkowski C, Geib AJ. Combined butalbital/acetaminophen/caffeine overdose: case files of the Robert Wood Johnson Medical School Toxicology Service. J Med Toxicol. 2012;8:424–31.CrossRefPubMedPubMedCentral
28.
go back to reference Berger AJ, Alford K. Cardiac arrest in a young man following excess consumption of caffeinated “energy drinks”. Med J Aust. 2009;190:41–3.PubMed Berger AJ, Alford K. Cardiac arrest in a young man following excess consumption of caffeinated “energy drinks”. Med J Aust. 2009;190:41–3.PubMed
30.
go back to reference Berger RE, Ganetsky M. An over-the-counter weight-loss supplement with a toxicity that may be unexpectedly difficult to treat. Intern Emerg Med. 2012;7(Suppl 2):S91–2.CrossRefPubMed Berger RE, Ganetsky M. An over-the-counter weight-loss supplement with a toxicity that may be unexpectedly difficult to treat. Intern Emerg Med. 2012;7(Suppl 2):S91–2.CrossRefPubMed
31.
go back to reference Seifert SM, Seifert SA, Schaechter JL, Bronstein AC, Benson BE, Hershorin ER, et al. An analysis of energy-drink toxicity in the National Poison Data System. Clin Toxicol (Phila). 2013;51:566–74.CrossRef Seifert SM, Seifert SA, Schaechter JL, Bronstein AC, Benson BE, Hershorin ER, et al. An analysis of energy-drink toxicity in the National Poison Data System. Clin Toxicol (Phila). 2013;51:566–74.CrossRef
32.
34.
go back to reference Campana C, Griffin PL, Simon EL. Caffeine overdose resulting in severe rhabdomyolysis and acute renal failure. Am J Emerg Med. 2014;32:111.e3–.e4.CrossRef Campana C, Griffin PL, Simon EL. Caffeine overdose resulting in severe rhabdomyolysis and acute renal failure. Am J Emerg Med. 2014;32:111.e3–.e4.CrossRef
35.
go back to reference Chiang WF, Liao MT, Cheng CJ, Lin SH. Rhabdomyolysis induced by excessive coffee drinking. Hum Exp Toxicol. 2014;33:878–81.CrossRefPubMed Chiang WF, Liao MT, Cheng CJ, Lin SH. Rhabdomyolysis induced by excessive coffee drinking. Hum Exp Toxicol. 2014;33:878–81.CrossRefPubMed
36.
go back to reference Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2011;3:89–96.CrossRefPubMed Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2011;3:89–96.CrossRefPubMed
37.
go back to reference Davies S, Lee T, Ramsey J, Dargan PI, Wood DM. Risk of caffeine toxicity associated with the use of ‘legal highs’ (novel psychoactive substances). Eur J Clin Pharmacol. 2012;68:435–9.CrossRefPubMed Davies S, Lee T, Ramsey J, Dargan PI, Wood DM. Risk of caffeine toxicity associated with the use of ‘legal highs’ (novel psychoactive substances). Eur J Clin Pharmacol. 2012;68:435–9.CrossRefPubMed
38.
go back to reference Hoyte C. The toxicity of energy drinks: myth or reality? Clin Toxicol (Phila). 2013;51:729–30.CrossRef Hoyte C. The toxicity of energy drinks: myth or reality? Clin Toxicol (Phila). 2013;51:729–30.CrossRef
39.
go back to reference O’Malley PA. Caffeinated energy drinks: risks assumed with consumption when competing, working, and drinking. Clin Nurse Spec. 2012;26:250–3.CrossRefPubMed O’Malley PA. Caffeinated energy drinks: risks assumed with consumption when competing, working, and drinking. Clin Nurse Spec. 2012;26:250–3.CrossRefPubMed
40.
go back to reference Suzuki H, Tanifuji T, Abe N, Maeda M, Kato Y, Shibata M, Fukunaga T. Characteristics of caffeine intoxication-related death in Tokyo, Japan, between 2008 and 2013. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2014;49:270–7.PubMed Suzuki H, Tanifuji T, Abe N, Maeda M, Kato Y, Shibata M, Fukunaga T. Characteristics of caffeine intoxication-related death in Tokyo, Japan, between 2008 and 2013. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2014;49:270–7.PubMed
41.
go back to reference Ishikawa T, Yuasa I, Endoh M. Non specific drug distribution in an autopsy case report of fatal caffeine intoxication. Leg Med (Tokyo). 2015;17:535–8.CrossRef Ishikawa T, Yuasa I, Endoh M. Non specific drug distribution in an autopsy case report of fatal caffeine intoxication. Leg Med (Tokyo). 2015;17:535–8.CrossRef
42.
go back to reference Tominaga M, Michiue T, Oritani S, Ishikawa T, Maeda H. Evaluation of postmortem drug concentrations in bile compared with blood and urine in forensic autopsy cases. J Anal Toxicol. 2016;40:367–73.CrossRefPubMed Tominaga M, Michiue T, Oritani S, Ishikawa T, Maeda H. Evaluation of postmortem drug concentrations in bile compared with blood and urine in forensic autopsy cases. J Anal Toxicol. 2016;40:367–73.CrossRefPubMed
43.
go back to reference Tominaga M, Michiue T, Ishikawa T, Inamori-Kawamoto O, Oritani S, Maeda H. Evaluation of postmortem drug concentrations in cerebrospinal fluid compared with blood and pericardial fluid. Forensic Sci Int. 2015;254:118–25.CrossRefPubMed Tominaga M, Michiue T, Ishikawa T, Inamori-Kawamoto O, Oritani S, Maeda H. Evaluation of postmortem drug concentrations in cerebrospinal fluid compared with blood and pericardial fluid. Forensic Sci Int. 2015;254:118–25.CrossRefPubMed
44.
go back to reference Byard RW. The potential forensic significance of traditional herbal medicines. J Forensic Sci. 2010;55:89–92.CrossRefPubMed Byard RW. The potential forensic significance of traditional herbal medicines. J Forensic Sci. 2010;55:89–92.CrossRefPubMed
45.
go back to reference Ozdemir B, Sahin I, Kapucu H, Celbis O, Karakoc Y, Erdogan S, et al. How safe is the use of herbal weight-loss products sold over the internet? Hum Exp Toxicol. 2013;32:101–6.CrossRefPubMed Ozdemir B, Sahin I, Kapucu H, Celbis O, Karakoc Y, Erdogan S, et al. How safe is the use of herbal weight-loss products sold over the internet? Hum Exp Toxicol. 2013;32:101–6.CrossRefPubMed
46.
go back to reference Khazan M, Hedayati M, Kobarfard F, Askari S, Azizi F. Identification and determination of synthetic pharmaceuticals as adulterants in eight common herbal weight loss supplements. Iran Red Crescent Med J. 2014;16:e15344.PubMedPubMedCentral Khazan M, Hedayati M, Kobarfard F, Askari S, Azizi F. Identification and determination of synthetic pharmaceuticals as adulterants in eight common herbal weight loss supplements. Iran Red Crescent Med J. 2014;16:e15344.PubMedPubMedCentral
Metadata
Title
Caffeine toxicity in forensic practice: possible effects and under-appreciated sources
Authors
Ian F. Musgrave
Rachael L. Farrington
Claire Hoban
Roger W. Byard
Publication date
01-09-2016
Publisher
Springer US
Published in
Forensic Science, Medicine and Pathology / Issue 3/2016
Print ISSN: 1547-769X
Electronic ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-016-9786-9

Other articles of this Issue 3/2016

Forensic Science, Medicine and Pathology 3/2016 Go to the issue